Legal
Walgreens to Pay $44 Million to Settle Theranos Fraud Claims
A Walgreens store in Pinole, California.
Photographer: David Paul Morris/BloombergThis article is for subscribers only.
Walgreens Boots Alliance Inc. has agreed to pay $44 million to settle class action claims by consumers who received flawed blood tests in Arizona and California through the pharmacy chain’s partnership with Theranos Inc.
The proposed settlement, which needs court approval, will provide consumers who participated in the lawsuit with “approximately double their out-of-pocket damages,” lawyers for plaintiffs said in a court filing Wednesday in federal court in Phoenix.